1-3 of 3
Clet Niyikiza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C90: HER2-targeted liposomal doxorubicin MM-302 has a favorable cardiosafety profile in preclinical models.

Elena Geretti, Joe Reynolds, Bart Hendriks, Isabelle Eckelhofer, Chris Espelin, Daniel Gaddy, Stephan Klinz, Helen Lee, Shannon Leonard, Ken Olivier, Sam Agresta, Clet Niyikiza, Ulrik Nielsen, Thomas Wickham
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C90.
https://doi.org/10.1158/1535-7163.TARG-11-C90
Published: 12 November 2011
View article titled, Abstract C90: HER2-targeted liposomal doxorubicin MM-302 has a favorable cardiosafety profile in preclinical models.
Journal Articles

Abstract C207: Identifying differential mechanisms of action for MM-398/PEP02, a novel nanotherapeutic encapsulation of irinotecan.

Stephan G. Klinz, Nancy Paz, Ashish Kalra, Jaeyeon Kim, Bart Hendriks, Daryl Drummond, Dmitri Kirpotin, Victor Moyo, C. Grace Yeh, Clet Niyikiza, Jonathan Fitzgerald
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C207.
https://doi.org/10.1158/1535-7163.TARG-11-C207
Published: 12 November 2011
View article titled, Abstract C207: Identifying differential mechanisms of action for MM-398/PEP02, a novel nanotherapeutic encapsulation of irinotecan.
Journal Articles

Homocysteine and Methylmalonic Acid: Markers to Predict and Avoid Toxicity from Pemetrexed Therapy

Clet Niyikiza, Sharyn D. Baker, David E. Seitz, Jackie M. Walling, Katrina Nelson, James J. Rusthoven, Sally P. Stabler, Paolo Paoletti, A. Hilary Calvert, Robert H. Allen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (7): 545–552.
Published: 01 May 2002
View article titled, Homocysteine and Methylmalonic Acid: Markers to Predict and Avoid Toxicity from Pemetrexed Therapy
Open the PDF for Homocysteine and Methylmalonic Acid: Markers to Predict and Avoid Toxicity from Pemetrexed Therapy in another window